Annual report
6788.TEDINET S100OD41
Period2021-04-01 → 2022-03-31
Filed2022-06-22
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 154
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥16.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥14.9bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥16.1bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥15.2bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.0bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.0bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥2.2bn | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥2.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.4bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.7bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.1bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.4bn | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.9bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥218m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.2bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥1.6bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥26.6bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥24.9bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥22.4bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥22.6bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥24.0bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.8bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.1bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.8bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥17.8bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥17.1bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥17.4bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥17.8bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.9bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.4bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥11.9bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.7bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.8bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.1bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥10.9bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.7bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.2bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥432m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥887m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.6bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥500m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥322m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥568m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥109m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥518m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.9bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥250.58 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥195.45 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.67 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥157.05 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥143.36 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥27.66 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥156.95 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥143.3 | 2017-04-01 → 2018-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥2,585.01 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,239.7 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,128.85 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,162.68 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,147.35 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 74.5% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.8% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.9% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.5% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.5% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 10.4% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.9% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 1.3% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.7% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 608 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 576 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 575 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 500 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 487 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥12.9bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥12.1bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥12.9bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥12.9bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥12.2bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.0bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥1.4bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.2bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.5bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.7bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.2bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.5bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.2bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥1.0bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥1.1bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.0bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥908m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥18.5bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥20.1bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥18.5bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥18.3bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥19.1bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.9bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥3.5bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥16.7bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥16.6bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥16.4bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥15.9bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥16.4bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥6.4bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.9bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥158.33 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥131.51 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥139.99 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥131.09 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.16 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥139.94 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥131 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥110.12 | 2017-04-01 → 2018-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥60 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,172.44 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,130.05 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,083.17 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,004.58 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,017.91 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 89.8% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.5% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.7% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.6% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.9% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.4% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.2% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.5% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 8,656,780 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,656,780 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,656,780 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,656,780 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,656,780 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 321 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 327 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 338 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 344 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 341 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥15m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥1.5bn |
| Medical Relatedreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥172m |
| Medical Relatedreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥98m |
| Medical Relatedreportable segment | employees | at 2022-03-31 | 88 pure |
| Medical Relatedreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.9bn |
| Medical Relatedreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.9bn |
| Medical Relatedreportable segment | segment assets | at 2022-03-31 | ¥6.1bn |
| Medical Relatedreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥177m |
| Water Health Carereportable segment | capex | 2021-04-01 → 2022-03-31 | ¥413m |
| Water Health Carereportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥315m |
| Water Health Carereportable segment | employees | at 2022-03-31 | 520 pure |
| Water Health Carereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥14.4bn |
| Water Health Carereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥14.4bn |
| Water Health Carereportable segment | segment assets | at 2022-03-31 | ¥19.0bn |
| Water Health Carereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1.8bn |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥585m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥413m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥16.3bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥16.3bn |
| —segment total | segment assets | at 2022-03-31 | ¥25.1bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥2.0bn |
| Reconciling Itemsreconciling | depreciation | 2020-04-01 → 2021-03-31 | ¥15m |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥1.4bn |
| Medical Relatedreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥511m |
| Medical Relatedreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥34m |
| Medical Relatedreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥1.6bn |
| Medical Relatedreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥1.6bn |
| Medical Relatedreportable segment | segment assets | at 2021-03-31 | ¥4.6bn |
| Medical Relatedreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥69m |
| Water Health Carereportable segment | capex | 2020-04-01 → 2021-03-31 | ¥528m |
| Water Health Carereportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥153m |
| Water Health Carereportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥13.3bn |
| Water Health Carereportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥13.3bn |
| Water Health Carereportable segment | segment assets | at 2021-03-31 | ¥18.9bn |
| Water Health Carereportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥2.1bn |
| —segment total | capex | 2020-04-01 → 2021-03-31 | ¥1.0bn |
| —segment total | depreciation | 2020-04-01 → 2021-03-31 | ¥187m |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥14.9bn |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥14.9bn |
| —segment total | segment assets | at 2021-03-31 | ¥23.5bn |
| —segment total | segment profit | 2020-04-01 → 2021-03-31 | ¥2.2bn |
| Medical Relatedreportable segment | employees | at 2022-03-31 | 4 pure |
| Water Health Carereportable segment | employees | at 2022-03-31 | 317 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,543
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | CurrentYearInstant | 26590946000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 2147.35 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 2162.68 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 2128.85 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 2239.70 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 2585.01 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 143.36 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 157.05 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 27.67 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 195.45 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 250.58 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | 143.30 | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | 156.95 | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | 27.66 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.725 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.755 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.749 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.698 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.745 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | 0.067 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | 0.072 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.013 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.089 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.104 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | 38.4 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | 36.8 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | 102.8 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 21.0 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 10.3 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | 2151872000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | 1875955000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | 1823395000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 2679334000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 1145267000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | -321503000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -500351000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -2644205000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -887111000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | 432240000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | -1890432000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | -3115357000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | -518443000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 109346000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | 568373000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 10920948000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 9135874000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant | 7790829000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 9677024000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |